Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
An J, Yan M, Yu N, Chennamadhavuni A, Furqan M, Mott SL, Loeffler BT, Kruser T, Sita TL, Feldman L, Nguyen R, Pasquinelli M, Hanna NH, Abu Hejleh T.
An J, et al.
Transl Lung Cancer Res. 2021 Aug;10(8):3608-3615. doi: 10.21037/tlcr-21-177.
Transl Lung Cancer Res. 2021.
PMID: 34584860
Free PMC article.